A Preparation for High Aqueous Dispersion Fe <sub>3</sub> O <sub>4</sub> with Controllable Particle Size and Adjustable Aggregation State in a Magnetic Field

The conventional synthesis of superparamagnetic Fe<sub>3</sub>O<sub>4</sub> superparamagnetic nanoparticles (Fe<sub>3</sub>O<sub>4</sub>SNPs) for biomedical applications often suffers from poor aqueous dispersibility, complex multistep processes, and potential toxicity from organic solvents or surfactants. Achieving precise control over both particle size and magnetic field-driven aggregation state in a biocompatible manner remains a significant challenge. A facile one-pot hydrothermal synthesis strategy was developed using a polysaccharide-iron complex as the precursor to prepare nano-Fe<sub>3</sub>O<sub>4</sub> with excellent water dispersibility. With this method, we achieved precise regulation of Fe<sub>3</sub>O<sub>4</sub> particle size (3.2-12.5 nm) and magnetic field-driven aggregation behavior by optimizing reaction conditions (such as sugar content, NaOH concentration, and reaction time), making them suitable for different biomedical scenarios such as the separation of active ingredients, in vivo targeted delivery, or MRI contrast agent. The solution of synthesized Fe<sub>3</sub>O<sub>4</sub>SNPs remained stable at room temperature for up to six months without any precipitation and did not exhibit significant toxicity at different particle sizes. In vitro MRI performance evaluation revealed that Fe<sub>3</sub>O<sub>4</sub>SNPs with a particle size of 8.1 nm exhibited a high transverse relaxation rate (r2 = 189.8 mM<sup>-1</sup> s<sup>-1</sup>) and a prominent r2/r1 ratio of 172.5, demonstrating potential as a T2 contrast agent; nanoparticles with a particle size of 4.0 nm displayed an r1 value approximately 1.6 times that of Gd-DTPA contrast agents, showing application potential as T1 contrast agents. This green synthesis method only uses water and polysaccharide iron complexes, thus providing a technical reference for the production of medical magnetic nanomaterials.

Authors

Institutions

Publication Details

Journal
Langmuir
Published
2026-02-03
DOI
https://doi.org/10.1021/acs.langmuir.5c05472
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Preparation for High Aqueous Dispersion Fe 3 O 4 with Controllable Particle Size and Adjustable Aggregation State in a Magnetic Field

Jinyu Chai, Yun Zhang, Jinhua Zhu, Wei Wei et al.
Langmuir
Nanoparticle-Based Drug Delivery
article

A Preparation for High Aqueous Dispersion Fe 3 O 4 with Controllable Particle Size and Adjustable Aggregation State in a Magnetic Field

Jinyu Chai, Yun Zhang, Jinhua Zhu, Wei Wei, Lu Liu, Yiwen Guo
article en

Abstract

The conventional synthesis of superparamagnetic Fe<sub>3</sub>O<sub>4</sub> superparamagnetic nanoparticles (Fe<sub>3</sub>O<sub>4</sub>SNPs) for biomedical applications often suffers from poor aqueous dispersibility, complex multistep processes, and potential toxicity from organic solvents or surfactants. Achieving precise control over both particle size and magnetic field-driven aggregation state in a biocompatible manner remains a significant challenge. A facile one-pot hydrothermal synthesis strategy was developed using a polysaccharide-iron complex as the precursor to prepare nano-Fe<sub>3</sub>O<sub>4</sub> with excellent water dispersibility. With this method, we achieved precise regulation of Fe<sub>3</sub>O<sub>4</sub> particle size (3.2-12.5 nm) and magnetic field-driven aggregation behavior by optimizing reaction conditions (such as sugar content, NaOH concentration, and reaction time), making them suitable for different biomedical scenarios such as the separation of active ingredients, in vivo targeted delivery, or MRI contrast agent. The solution of synthesized Fe<sub>3</sub>O<sub>4</sub>SNPs remained stable at room temperature for up to six months without any precipitation and did not exhibit significant toxicity at different particle sizes. In vitro MRI performance evaluation revealed that Fe<sub>3</sub>O<sub>4</sub>SNPs with a particle size of 8.1 nm exhibited a high transverse relaxation rate (r2 = 189.8 mM<sup>-1</sup> s<sup>-1</sup>) and a prominent r2/r1 ratio of 172.5, demonstrating potential as a T2 contrast agent; nanoparticles with a particle size of 4.0 nm displayed an r1 value approximately 1.6 times that of Gd-DTPA contrast agents, showing application potential as T1 contrast agents. This green synthesis method only uses water and polysaccharide iron complexes, thus providing a technical reference for the production of medical magnetic nanomaterials.

LangmuirVol. 42(6)
Henan University (CN), Institut des Sciences des Plantes de Montpellier (FR)
Openalex Percentile: Top 71%
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.